Get started
Author

Yuexian Li

Observed name: Yue-Xian Li
ORCID: 0000-0002-4804-119X
Observed ORCID: 0000-0002-4804-119X
OpenAlex ID: A5102995201
Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
2020 · Xiaofei Zhou, Farhad Sedarati, et al. · Investigational New Drugs · 31
PDF
The Influences of I h on Temporal Summation in Hippocampal CA1 Pyramidal Neurons: A Modeling Study
2003 · Adrien E. Desjardins, Yue-Xian Li, et al. · Journal of Computational Neuroscience · 23
Clustering in Small Networks of Excitatory Neurons with Heterogeneous Coupling Strengths
2003 · Yue-Xian Li, Yu-qing Wang, et al. · Journal of Computational Neuroscience · 23
Simple models for quorum sensing: Nonlinear dynamical analysis
2011 · Wei-Yin Chiang, Yue-Xian Li, et al. · Physical Review E · 20
Robust Synchrony and Rhythmogenesis in Endocrine Neurons via Autocrine Regulations In Vitro and In Vivo
2008 · Yue-Xian Li, Anmar Khadra · Bulletin of Mathematical Biology · 20
A Mathematical Model for the Actions of Activin, Inhibin, and Follistatin on Pituitary Gonadotrophs
2008 · Richard Bertram, Yue-Xian Li · Bulletin of Mathematical Biology · 19
Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles
2015 · Yuexian Li, Jiyeon Woo, et al. · Bioorganic & Medicinal Chemistry Letters · 16
Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24‐hydroxylase inhibitor soticlestat in healthy volunteers
2023 · Wei Yin, T. Eric Ballard, et al. · British Journal of Clinical Pharmacology · 12
PDF
Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novel selective inhibitor of breast cancer resistance protein (BCRP)
2017 · Mingxiang Liao, Bei-Ching Chuang, et al. · Xenobiotica · 9
Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects
2024 · Hao Chen, Abhi Shah, et al. · Drug Metabolism and Disposition · 8
A Computational Study of Spike Time Reliability in Two Types of Threshold Dynamics
2013 · Na Yu, Yue-Xian Li, et al. · The Journal of Mathematical Neuroscience · 8
PDF
Clustering in neural networks with heterogeneous and asymmetrical coupling strengths
2003 · Yue-Xian Li · Physica D Nonlinear Phenomena · 8
Mass balance, routes of excretion, and pharmacokinetics of investigational oral [14C]-alisertib (MLN8237), an Aurora A kinase inhibitor in patients with advanced solid tumors
2018 · Xiaofei Zhou, Sandeepraj Pusalkar, et al. · Investigational New Drugs · 7
Synthesis of C‐14‐labeled novel IKK inhibitor: 2‐[14C]‐N‐(6‐chloro‐9H‐pyrido [3,4‐b]indol‐8‐yl)‐3‐pyridinecarboxamide
2005 · Yuexian Li, Shimoga R. Prakash · Journal of Labelled Compounds and Radiopharmaceuticals · 6
Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist
2022 · Sandeepraj Pusalkar, Swapan K. Chowdhury, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 4
PDF
Abstract B216: Mass balance, routes of excretion and pharmacokinetics of investigational oral [14C]alisertib (MLN8237) in patients with advanced solid tumors or lymphoma.
2013 · Xiaofei Zhou, Sandeepraj Pusalkar, et al. · Molecular Cancer Therapeutics · 4
Stochastic phase dynamics of noise driven synchronization of two conditional coherent oscillators
2012 · William F. Thompson, Rachel Kuske, et al. · Discrete and Continuous Dynamical Systems · 4
Synthesis of three isotopically labeled versions and a metabolite of Aurora A kinase inhibitor
2009 · Yuexian Li, Shimoga R. Prakash · Journal of Labelled Compounds and Radiopharmaceuticals · 3
Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK‐700) in Healthy Male Subjects: A Phase 1, Open‐Label, Single‐Dose Study
2015 · Ajit Suri, Sandeepraj Pusalkar, et al. · Clinical Pharmacology in Drug Development · 2
Radiolabeled APIs for the Conduct of Human ADME Studies of Oncology Compounds
2017 · Yuexian Li, Mihaela Plesescu, et al. · International Journal of Cancer and Clinical Research
PDF
Synthesis of isotopically labeled versions of L‐MTP‐PE (mifamurtide) and MDP
2013 · Yuexian Li, Mihaela Plesescu, et al. · Journal of Labelled Compounds and Radiopharmaceuticals
Treatment status of environment protection to harness PVC production
2004 · Yuexian Li · China Chlor-Alkali
Works count: 22
Citation count: 227
H-index: 9
I10-index: 8
Year
Topic
Type